A strong start to Q1 earnings season and optimism that the U.S. and China will avoid a full-blown trade war has helped stocks rebound from early-April volatility over the past week and a half, renewing investor confidence around the world.
Fresh bullishness over the past few trading periods has inspired positive trading in several key global markets. But interestingly enough, a number of optimistic headlines in the budding marijuana industry has led to an even stronger recovery in this popular investing area.
Canadian marijuana stocks witnessed a massive selloff at the beginning of the month after industry bellwether Canopy Growth Corp. failed to defend its 50-day moving average. These trendy companies are followed by active traders with formulaic strategies, so technical events like this can cause plenty of movement.
But investors who take this market seriously understand that there are a variety of diverse options to focus on. With this in mind, let’s take a closer look at how a few popular stocks with exposure to the marijuana industry have performed over the past few weeks.
Cronos Group Inc.
Cronos Group became the first pure-play medical marijuana company to list on an American exchange when it debuted on the Nasdaq in late February. The firm invests in companies that are licensed to produce and sell medical-grade pot. Here’s how the stock has performed over the past two weeks:
CRON has clearly been on fire lately, and that might be because the stock is finally starting to see legitimate, bullish analyst coverage. In fact, about a week ago, Cronos shares received their first upgrade since the company debuted on the Nasdaq, with Toronto-based investment bank GMP Securities raising the stock from hold to buy.
Innovative Industrial Properties, Inc. (IIPR )
Innovative Industrial Properties is a REIT focused on the acquisition, ownership and management of specialized industrial properties for medical-use cannabis facilities.
IIPR has also generated some solid momentum over the past two weeks. Investors are likely excited about the company’s recent acquisition of an 89,000-square-foot facility in Pennsylvania, which was announced last week. The deal included a new tenant relationship with Vireo Health, a cultivation and medical dispensary business.
GW Pharmaceuticals PLC (GWPH )
GW Pharmaceuticals is a U.K.-based biopharmaceutical company that is developing cannabinoid treatments. The firm sticks out from the above stocks because its stock behaves much more like a traditional research biotech than a weed-focused REIT or investment fund.
GWPH has started to pick up pace as investors gear up for the FDA to approve its cannabis-based anti-seizure drug, Epidiolex. The regulatory body is meeting this week to discuss the benefits and risks of the treatment, and if that conversation goes well, it will consider approving the drug on June 27.
Want more market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!
Can Hackers Put Money INTO Your Portfolio?
Earlier this year, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.
Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.
Download the new report now>>